Equity Profile
Pre-Earnings Brief
Merit Medical Systems Inc (MMSI) operates in the health care sector, focusing on medical supplies. The company provides a range of products used in various medical procedures, which are essential for patient care and hospital operations.
EPS
Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
Revenue figures help gauge the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
8Q
EPS Beat Rate
100%
Avg EPS Surprise
+14.44%
Avg Stock Reaction
-0.13%
In Q4-2025, Merit Medical reported an EPS of $1.04, significantly beating the estimate of $0.85. The stock reacted positively, increasing by 1.00% the following day.
Management Promises & Guidance
Analysts expect Merit Medical to continue its strong performance with an EPS of $0.83 and revenue of $378 million. The company has a solid track record of beating earnings expectations.
Bull Case
If Merit Medical delivers an EPS above $0.83, it could reinforce investor confidence and lead to a positive stock reaction, given its history of surprises.
Bear Case
Conversely, if the company fails to meet these expectations, it may raise concerns about its growth trajectory and could lead to a negative stock reaction.
EPS
$0.83Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$378MRevenue figures help gauge the company's sales performance and market demand for its products.
Expectations
The print will turn on these two things.
Q1
Will EPS exceed the consensus estimate of $0.83?
A beat on EPS would continue the company's trend of exceeding expectations and could drive the stock higher.
Q2
What are the revenue figures compared to the consensus of $378M?
Revenue performance is crucial for assessing the company's growth and market demand for its products.
Edge
Why consensus could be wrong
The consensus may underestimate the company's ability to leverage new product lines, which could drive higher-than-expected revenue growth.
Supporting Evidence
Merit Medical has consistently beaten EPS estimates in the past, indicating strong operational execution.
The options market is pricing a larger move than historical averages, suggesting potential for significant volatility.
The company's recent product launches may not be fully reflected in analyst models.
Key Risk
If revenue significantly exceeds $378M, it could challenge the current bearish sentiment.
Edge
Pre-commit to what would confirm each case.
The market is debating whether Merit Medical can maintain its strong earnings momentum in a competitive landscape.
Bull Confirmed If
An EPS of $0.85 or higher would confirm the bullish outlook.
Bear Confirmed If
An EPS below $0.81 would support the bearish case.
Pre-Earnings Positioning
Implied Move
±3.66%
Historical Avg
±1.2%
The options market is pricing in a potential move of about 3.66% in either direction following the earnings report.
Options are pricing ±3.7% while MMSI has averaged ±1.2% over the last 8 prints — setup is pricing rich.
30d HV
26.0%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Merit Medical beats expectations, history suggests the stock could rise by around 1.16% on average, confirming positive sentiment.
In-Line / Cautious
An in-line report may lead to a muted reaction, as investors await further commentary on future growth.
Miss
If the company misses expectations, the stock could decline, potentially reflecting the average reaction of around -0.13%.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AVALONBAY CMNTYS INC REIT